Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Voltage-gated calcium channel activity and complex related genes and schizophrenia: A systematic investigation based on Han Chinese population.

Zhang T, Zhu L, Ni T, Liu D, Chen G, Yan Z, Lin H, Guan F, Rice JP.

J Psychiatr Res. 2018 Nov;106:99-105. doi: 10.1016/j.jpsychires.2018.09.020. Epub 2018 Oct 3.

PMID:
30308413
2.

The NDE1 genomic locus can affect treatment of psychiatric illness through gene expression changes related to microRNA-484.

Bradshaw NJ, Ukkola-Vuoti L, Pankakoski M, Zheutlin AB, Ortega-Alonso A, Torniainen-Holm M, Sinha V, Therman S, Paunio T, Suvisaari J, Lönnqvist J, Cannon TD, Haukka J, Hennah W.

Open Biol. 2017 Nov;7(11). pii: 170153. doi: 10.1098/rsob.170153.

3.

Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats.

Snyder GL, Prickaerts J, Wadenberg ML, Zhang L, Zheng H, Yao W, Akkerman S, Zhu H, Hendrick JP, Vanover KE, Davis R, Li P, Mates S, Wennogle LP.

Psychopharmacology (Berl). 2016 Sep;233(17):3113-24. doi: 10.1007/s00213-016-4346-2. Epub 2016 Jun 24.

4.

New insights into PDE4B inhibitor selectivity: CoMFA analyses and molecular docking studies.

Guariento S, Bruno O, Fossa P, Cichero E.

Mol Divers. 2016 Feb;20(1):77-92. doi: 10.1007/s11030-015-9631-1. Epub 2015 Aug 20.

PMID:
26290462
5.

Mitotic activation of the DISC1-inducible cyclic AMP phosphodiesterase-4D9 (PDE4D9), through multi-site phosphorylation, influences cell cycle progression.

Sheppard CL, Lee LC, Hill EV, Henderson DJ, Anthony DF, Houslay DM, Yalla KC, Cairns LS, Dunlop AJ, Baillie GS, Huston E, Houslay MD.

Cell Signal. 2014 Sep;26(9):1958-74. doi: 10.1016/j.cellsig.2014.04.023. Epub 2014 May 9.

PMID:
24815749
6.

DISC1-ATF4 transcriptional repression complex: dual regulation of the cAMP-PDE4 cascade by DISC1.

Soda T, Frank C, Ishizuka K, Baccarella A, Park YU, Flood Z, Park SK, Sawa A, Tsai LH.

Mol Psychiatry. 2013 Aug;18(8):898-908. doi: 10.1038/mp.2013.38. Epub 2013 Apr 16.

7.

Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment.

Clark SL, Souza RP, Adkins DE, Aberg K, Bukszár J, McClay JL, Sullivan PF, van den Oord EJ.

Pharmacogenet Genomics. 2013 Feb;23(2):69-77. doi: 10.1097/FPC.0b013e32835ca260.

8.

Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex.

Kuroiwa M, Snyder GL, Shuto T, Fukuda A, Yanagawa Y, Benavides DR, Nairn AC, Bibb JA, Greengard P, Nishi A.

Psychopharmacology (Berl). 2012 Feb;219(4):1065-79. doi: 10.1007/s00213-011-2436-8. Epub 2011 Aug 11.

9.

2-{4-[-Pyridin-4-yl-1-(2-[18F]fluoro-ethyl)-1H-pyrazol-3-yl]-phenoxymethyl}-quinoline.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 Dec 20 [updated 2011 Mar 2].

10.

Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety.

Burgin AB, Magnusson OT, Singh J, Witte P, Staker BL, Bjornsson JM, Thorsteinsdottir M, Hrafnsdottir S, Hagen T, Kiselyov AS, Stewart LJ, Gurney ME.

Nat Biotechnol. 2010 Jan;28(1):63-70. doi: 10.1038/nbt.1598. Epub 2009 Dec 27.

PMID:
20037581
11.

The DISC1 pathway modulates expression of neurodevelopmental, synaptogenic and sensory perception genes.

Hennah W, Porteous D.

PLoS One. 2009;4(3):e4906. doi: 10.1371/journal.pone.0004906. Epub 2009 Mar 20.

12.

Association between genes of Disrupted in schizophrenia 1 (DISC1) interactors and schizophrenia supports the role of the DISC1 pathway in the etiology of major mental illnesses.

Tomppo L, Hennah W, Lahermo P, Loukola A, Tuulio-Henriksson A, Suvisaari J, Partonen T, Ekelund J, Lönnqvist J, Peltonen L.

Biol Psychiatry. 2009 Jun 15;65(12):1055-62. doi: 10.1016/j.biopsych.2009.01.014. Epub 2009 Feb 28.

13.

DISC1, PDE4B, and NDE1 at the centrosome and synapse.

Bradshaw NJ, Ogawa F, Antolin-Fontes B, Chubb JE, Carlyle BC, Christie S, Claessens A, Porteous DJ, Millar JK.

Biochem Biophys Res Commun. 2008 Dec 26;377(4):1091-6. doi: 10.1016/j.bbrc.2008.10.120. Epub 2008 Nov 5. Erratum in: Biochem Biophys Res Commun. 2009 Jul 3;384(3):400.

PMID:
18983980
14.

Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme.

Siuciak JA, McCarthy SA, Chapin DS, Martin AN.

Psychopharmacology (Berl). 2008 Mar;197(1):115-26. Epub 2007 Dec 1.

PMID:
18060387
15.

PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6).

Cheung YF, Kan Z, Garrett-Engele P, Gall I, Murdoch H, Baillie GS, Camargo LM, Johnson JM, Houslay MD, Castle JC.

J Pharmacol Exp Ther. 2007 Aug;322(2):600-9. Epub 2007 May 22.

16.

Acute amygdalar activation induces an upregulation of multiple monoamine G protein coupled pathways in rat hippocampus.

Benes FM, Burke RE, Walsh J, Berretta S, Matzilevich D, Minns M, Konradi C.

Mol Psychiatry. 2004 Oct;9(10):932-45, 895.

PMID:
15170462

Supplemental Content

Loading ...
Support Center